Osiris Therapeutics, Inc. (NASDAQ:OSIR)

CAPS Rating: 1 out of 5

A stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory, orthopedic and cardiovascular areas.

Recs

0
Player Avatar riegonla (40.86) Submitted: 10/15/2009 1:43:04 AM : Outperform Start Price: $6.93 OSIR Score: -30.82

14 US$ 1 Nov 2009

Report this Post 1 Comment
Member Avatar riegonla (40.86) Submitted: 11/22/2009 12:16:00 PM
Recs: 0

14,1 US$ 20 Ener 2010

Featured Broker Partners


Advertisement